This compound is primarily utilized in the development of pharmaceutical agents, particularly in the synthesis of chiral molecules. Its structure, featuring a trifluoromethyl group and an amino acid moiety, makes it a valuable intermediate in the creation of drugs targeting neurological disorders, such as epilepsy and anxiety. The trifluoromethyl group enhances the compound's metabolic stability and bioavailability, which is crucial for effective drug design. Additionally, it is employed in research focused on enzyme inhibition studies, where its chiral center plays a key role in interacting with biological targets. Its application extends to the field of medicinal chemistry, where it aids in the discovery of novel therapeutic compounds with improved efficacy and selectivity.